Possible advance for some late-stage lung cancer patients

Possible advance for some late-stage lung cancer patients
Surgical biopsy could pave way for targeted treatments, study says.

(HealthDay)—Surgical biopsy is safe for certain late-stage lung cancer patients and could improve their chances of getting treated with newer types of drugs that target cancer-related genetic mutations, a new small study reveals.

In many cases, is too dangerous for these , so less-invasive methods are used, including fine-needle aspiration and core needle biopsies. However, these less invasive techniques sometimes gather too few tumor cells to perform the molecular testing needed to prescribe newer targeted drugs, the researchers said.

Their study included 25 patients with late-stage non-small cell lung cancer who had surgical biopsies. Most of the biopsies were performed using video-assisted surgery that requires general anesthesia but only small incisions.

Five patients experienced a complication, three of which were minor. Surgical biopsy identified potentially targetable in 19 of the 25 patients, and changed the treatment strategy in more than half.

Ten of the 19 patients were determined to be eligible for enrollment in a clinical trial of targeted drug treatment, according to the study in the July issue of the Journal of Thoracic and Cardiovascular Surgery.

"We will be allowing more people to be eligible for clinical trials, and ultimately that will provide value to the patient and access to treatments they may not have had otherwise," lead author David Cooke, head of general thoracic surgery at the University of California, Davis Medical Center, said in a university news release.

However, surgical biopsy should be used on a late-stage patient only after the case has been reviewed by a team of experts, including lung and cancer specialists, a radiologist and surgeon, he said.

More information: The U.S. National Library of Medicine has more about lung cancer.

Related Stories

Surgical breast biopsy not overused, study suggests

date Feb 01, 2012

Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a study in the February issue of the Journal of the American College of Radiology. Surgical breast biopsies are mo ...

MRI-guided biopsy for brain cancer improves diagnosis

date May 01, 2014

Neurosurgeons at UC San Diego Heath System have, for the first time, combined real-time magnetic resonance imaging (MRI) technology with novel non-invasive cellular mapping techniques to develop a new biopsy approach that ...

Recommended for you

Mammography benefits overestimated, review says

date 5 hours ago

An in-depth review of randomised trials on screening for breast, colorectal, cervical, prostate and lung cancers, published in the Journal of the Royal Society of Medicine, shows that the benefits of mammographic screening are li ...

Extended-field IMRT does not increase duodenal toxicity risk

date 7 hours ago

A study of women with cervical or endometrial cancer who require treatment to the para-aortic (PA) lymph nodes can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.